| Jul 17 |
Bullish On Mirum Pharmaceuticals: Enhanced Portfolio With Strategic Acquisition
|
| Jul 12 |
Mirum Pharmaceuticals (NASDAQ:MIRM) delivers shareholders solid 23% CAGR over 5 years, surging 11% in the last week alone
|
| Jul 12 |
Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves
|
| Jul 9 |
Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion
|
| Jul 8 |
Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
|
| Jul 8 |
Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
|
| Jun 28 |
MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
|
| Jun 28 |
Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
|
| Jun 25 |
Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling
|
| Jun 18 |
Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
|
